Innovent Announced 2022 Interim Results and Business Updates
Leading the Way in Developing a More Sustainable Business Model for Innovative Biopharmaceutical Companies Commercial Model and Platform Upgraded to Stage 2.0 A Robust Pipeline of 34 Valuable Assets Supporting Continuously Growth Momentum ROCKVILLE, Md. and SUZHOU, China, Aug. 25, 2022…
Comments Off on Innovent Announced 2022 Interim Results and Business Updates